Hansa Biopharma AB
HNSA
Insider Trading Activity
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-11 | B Purchase |
Other member of the company's administrative, management or supervisory body |
82,234
31.00
SEK4,077,744 |
82,234 | 31.00 | SEK4,077,744 | |
| 2026-02-17 | 2026-02-16 | S Sale |
Member of the Board of Directors Through Devin Holden, a closely affiliated person Director |
16,675
118.55
SEK1,691,793 |
16,675 | 118.55 | SEK1,691,793 | |
| 2026-02-17 | 2026-02-13 | S Sale |
Member of the Board of Directors Through Devin Holden, a closely affiliated person Director |
62,151
44.24
SEK3,680,340 |
62,151 | 44.24 | SEK3,680,340 | |
| 2025-11-10 | 2025-11-07 | B Purchase |
Employee Representative of the Board of Directors or deputy Employee Representative of the Board of Directors, Chief Financial Officer (CFO) Through Charles Ballantyne, a closely affiliated person |
25,000
2.83
US$70,854 |
25,000 | 2.83 | US$70,854 | |
| 2025-08-12 | 2025-08-05 | B Purchase |
Chairman of the Board of Directors Director |
17,067
30.64
SEK522,933 |
17,067 | 30.64 | SEK522,933 | |
| 2025-07-29 | 2025-07-28 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
50,000
27.40
SEK1,370,000 |
50,000 | 27.40 | SEK1,370,000 | |
| 2025-07-29 | 2025-07-27 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
1,652,500
10.89
SEK17,995,725 |
1,652,500 | 10.89 | SEK17,995,725 | |
| 2025-07-29 | 2025-07-24 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
100,000
27.00
SEK2,700,000 |
100,000 | 27.00 | SEK2,700,000 | |
| 2024-06-25 | 2024-06-17 | B Purchase |
Other member of the company's administrative, management or supervisory body |
17,600
0.00
SEK0 |
17,600 | 0.00 | SEK0 | |
| 2024-02-08 | 2024-02-06 | B Purchase |
Chairman of the Board of Directors Director |
10,000
38.88
SEK388,800 |
10,000 | 38.88 | SEK388,800 | |
| 2023-12-08 | 2023-12-07 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
5,000
23.03
SEK115,142 |
5,000 | 23.03 | SEK115,142 | |
| 2022-08-02 | 2022-07-19 | B Purchase |
Chairman of the Board of Directors Director |
14,500
71.19
SEK1,032,193 |
14,500 | 71.19 | SEK1,032,193 | |
| 2022-06-22 | 2022-06-17 | S Sale |
Other member of the company's administrative, management or supervisory body |
2,591
49.99
SEK129,524 |
2,591 | 49.99 | SEK129,524 | |
| 2022-06-22 | 2022-06-17 | B Purchase |
Other member of the company's administrative, management or supervisory body |
5,155
0.00
SEK0 |
5,155 | 0.00 | SEK0 | |
| 2022-05-20 | 2022-05-20 | B Purchase |
Other senior executive Officer |
3,300
63.09
SEK208,197 |
3,300 | 63.09 | SEK208,197 | |
| 2022-04-26 | 2022-04-26 | B Purchase |
Other member of the company's administrative, management or supervisory body Through Anders Lanner, a closely affiliated person |
1,000
58.15
SEK58,150 |
1,000 | 58.15 | SEK58,150 | |
| 2022-03-16 | 2022-03-16 | B Purchase |
Other member of the company's administrative, management or supervisory body |
3,000
58.00
SEK174,000 |
3,000 | 58.00 | SEK174,000 | |
| 2021-07-19 | 2021-07-16 | B Purchase |
Chairman of the Board of Directors Director |
10,000
112.22
SEK1,122,200 |
10,000 | 112.22 | SEK1,122,200 | |
| 2021-07-16 | 2021-07-16 | B Purchase |
Chief Executive Officer (CEO)/Managing Directory Officer |
2,000
111.19
SEK222,371 |
2,000 | 111.19 | SEK222,371 | |
| 2021-05-12 | 2021-05-11 | B Purchase |
Other member of the company's administrative, management or supervisory body |
1,200
140.75
SEK168,900 |
1,200 | 140.75 | SEK168,900 |
More insider trading research around Hansa Biopharma AB
